Media enquiries
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.
Do you have
any question?
Saint-Cloud, France – December 16, 2021 – Ethypharm, a European pharmaceutical company specialising in the fields of the Central Nervous System and Injectable Hospital Drugs, announces that it has obtained the LUCIE 26000 label and joins Europe’s leading committed and responsible community. A first for a pharmaceutical company. This certification initially concerns Ethypharm’s main European subsidiaries: United Kingdom, France and Germany. This certification reflects Ethypharm’s commitment to a CSR approach that is fully integrated into its development and respects all its stakeholders.
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.